Cargando…
Modeling the Efficacy of Oncolytic Adenoviruses In Vitro and In Vivo: Current and Future Perspectives
Oncolytic adenoviruses (OAd) selectively target and lyse tumor cells and enhance anti- tumor immune responses. OAds have been used as promising cancer gene therapies for many years and there are a multitude of encouraging pre-clinical studies. However, translating OAd therapies to the clinic has had...
Autores principales: | McKenna, Mary K., Rosewell-Shaw, Amanda, Suzuki, Masataka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139921/ https://www.ncbi.nlm.nih.gov/pubmed/32155969 http://dx.doi.org/10.3390/cancers12030619 |
Ejemplares similares
-
Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment
por: Rosewell Shaw, Amanda, et al.
Publicado: (2018) -
Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors
por: Rosewell Shaw, Amanda, et al.
Publicado: (2021) -
Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies
por: Wang, Daniel, et al.
Publicado: (2023) -
HydrAd: A Helper-Dependent Adenovirus Targeting Multiple Immune Pathways for Cancer Immunotherapy
por: Rosewell Shaw, Amanda, et al.
Publicado: (2022) -
Increasing the Efficacy of Oncolytic Adenovirus Vectors
por: Toth, Karoly, et al.
Publicado: (2010)